Status:

RECRUITING

Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)

Lead Sponsor:

Prolacta Bioscience

Collaborating Sponsors:

Medical University of Vienna

Federal University Teaching Hospital, Feldkirch, Austria

Conditions:

Prematurity

Vascular Aging

Eligibility:

All Genders

1-5 years

Phase:

NA

Brief Summary

Early vascular aging has its origins in fetal and neonatal life. The NEOVASC clinical trial aims to determine the effects of an exclusive human milk diet in extremely preterm infants on long-term card...

Detailed Description

Early vascular aging has its origins in fetal and neonatal life. This early period of life plays an important role in the development of obesity, high blood pressure, abnormalities in lipid metabolism...

Eligibility Criteria

Inclusion

  • Preterm-born group:
  • Extremely preterm infants with a birth weight of 500-1250g.
  • Feeding is NPO or exclusive human milk prior to enrollment.
  • Parent(s) willing to sign informed consent.-

Exclusion

  • Infants with a birth weight \<500g or \>1250g
  • Subjects diagnosed with inborn errors of metabolism such as galactosemia, phenylketonuria
  • Subjects who have not been NPO or fed exclusive human milk diet prior to enrollment.
  • Presence of major congenital malformation.
  • Presence of intestinal perforation or Stage 2 Necrotizing enterocolitis prior to enrollment.
  • Parent(s) not willing to sign informed consent.
  • Unable to participate for any reason based on the decision of the study investigator (e.g. unlikely to survive the study period).
  • Term-born group:
  • Inclusion criteria
  • Term-born children with an adequate birth weight
  • Parent(s) willing to sign informed consent
  • Exclusion criteria
  • Subjects with acute or chronic illness
  • Parent(s) not willing to sign informed consent

Key Trial Info

Start Date :

October 9 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2028

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04413994

Start Date

October 9 2020

End Date

June 1 2028

Last Update

August 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University of Innsbruck

Innsbruck, Tyrol, Austria, A-6020